Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bivalirudin vs heparin in primary PCI for STEMI
CTR20160700Phase 2Active
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Start
- Sep 2016
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bivalirudin in myocardial infarction (MI), sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd.. Started Sep 2016; status: active.
02
Drugs
bivalirudin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on CTR20160700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160700.